MTX
This suggests that additive triple DMARD       combination therapy of a low dose of sulfhydryl compounds, SSZ and MTX could be a       useful drug therapy for the treatment of RA patients, even those who are       refractory.
This suggests that additive triple DMARD       combination therapy of a low dose of sulfhydryl compounds,  @PREDICAT$  @SUBJECT$  could be a       useful drug therapy for the treatment of RA  @OBJECT$ , even those who are       refractory.